{
  "ticker": "NTRA",
  "company_name": "Natera, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06476717",
      "title": "Donor-derived Cell-free DNA in Kidney Transplant Recipients",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Kidney Transplantation, Acute Rejection of Renal Transplant",
      "start_date": "2021-10-21",
      "completion_date": "2024-05-20",
      "enrollment": 0,
      "sponsor": "Institute for Clinical and Experimental Medicine"
    },
    {
      "nct_id": "NCT05756088",
      "title": "Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA",
      "status": "WITHDRAWN",
      "phase": "",
      "condition": "Cardiac Allograft Vasculopathy, Endothelial Dysfunction, Microvascular Coronary Artery Disease",
      "start_date": "2025-12",
      "completion_date": "2030-06",
      "enrollment": 0,
      "sponsor": "Yale University"
    },
    {
      "nct_id": "NCT02278874",
      "title": "High Risk Multiple Gestation Study",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities",
      "start_date": "2014-08",
      "completion_date": "2019-03",
      "enrollment": 0,
      "sponsor": "Natera, Inc."
    },
    {
      "nct_id": "NCT04239703",
      "title": "Trifecta-Kidney cfDNA-MMDx Study",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Kidney Transplant Rejection",
      "start_date": "2019-12-01",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "University of Alberta"
    },
    {
      "nct_id": "NCT05081024",
      "title": "Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8",
      "start_date": "2021-09-03",
      "completion_date": "2026-09-03",
      "enrollment": 0,
      "sponsor": "OHSU Knight Cancer Institute"
    },
    {
      "nct_id": "NCT04561453",
      "title": "Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer, Intrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma, Distal Bile Duct Cancer",
      "start_date": "2020-07-08",
      "completion_date": "2025-04-04",
      "enrollment": 0,
      "sponsor": "University of Washington"
    },
    {
      "nct_id": "NCT07292285",
      "title": "The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial.",
      "status": "NOT_YET_RECRUITING",
      "phase": "",
      "condition": "Cancer of the Rectum",
      "start_date": "2026-01-01",
      "completion_date": "2030-06-30",
      "enrollment": 0,
      "sponsor": "University of Colorado, Denver"
    },
    {
      "nct_id": "NCT05846113",
      "title": "Renasight Clinical Application, Review and Evaluation (RenaCARE) Study",
      "status": "UNKNOWN",
      "phase": "NA",
      "condition": "Kidney Diseases",
      "start_date": "2021-06-07",
      "completion_date": "2025-08",
      "enrollment": 0,
      "sponsor": "Natera, Inc."
    },
    {
      "nct_id": "NCT05205551",
      "title": "Prospera Test Evaluation in Cardiac Transplant (ProTECT)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "",
      "condition": "Heart Transplant Rejection",
      "start_date": "2021-10-01",
      "completion_date": "2027-06-30",
      "enrollment": 0,
      "sponsor": "Natera, Inc."
    },
    {
      "nct_id": "NCT06450314",
      "title": "Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Metastatic Breast Cancer, HER2-positive Breast Cancer",
      "start_date": "2025-01-25",
      "completion_date": "2029-12-15",
      "enrollment": 0,
      "sponsor": "UNICANCER"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "": 34,
      "NA": 4,
      "PHASE2": 5,
      "PHASE4": 1,
      "PHASE1": 3,
      "EARLY_PHASE1": 1,
      "PHASE3": 1,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 13,
      "WITHDRAWN": 6,
      "RECRUITING": 17,
      "TERMINATED": 4,
      "NOT_YET_RECRUITING": 3,
      "UNKNOWN": 2,
      "ACTIVE_NOT_RECRUITING": 5
    },
    "active_trials": 22,
    "completed_trials": 13,
    "conditions": [
      "22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21, Trisomy 18, Trisomy 13, Monosomy X, Sex Chromosome Abnormalities, Cri-du-Chat Syndrome, Angelman Syndrome, Prader-Willi Syndrome, 1p36 Deletion Syndrome",
      "Adnexal Mass",
      "Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer, Intrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma, Distal Bile Duct Cancer",
      "Breast Cancer",
      "Breast Cancer, Lung Cancer, Muscle Invasive Bladder Cancer, Rectal Cancer, Pancreatic Cancer, Ovarian Cancer, Gastroesophageal Cancer, Prostate Cancer, Melanoma, Head and Neck Cancer, Uterine Cancer, Liver Cancer",
      "Breast Cancer, Oestrogen Receptor Positive Breast Cancer",
      "Cancer of the Rectum",
      "Carcinoma, Hepatocellular, Liver Cell Carcinoma",
      "Cardiac Allograft Vasculopathy, Endothelial Dysfunction, Microvascular Coronary Artery Disease",
      "Chromosome 13 Aneuploidy, Chromosome 18 Aneuploidy, Chromosome 21 Aneuploidy, Sex Chromosome Aberrations, Other Microdeletions",
      "Colo-rectal Cancer",
      "Colon Adenocarcinoma, Colorectal Cancer",
      "Colon Cancer",
      "Colorectal Cancer Screening",
      "Colorectal Cancer, Colon Cancer",
      "Colorectal Cancer, Melanoma, Non-small Cell Lung Cancer",
      "Heart Transplant",
      "Heart Transplant Failure and Rejection",
      "Heart Transplant Rejection",
      "Hereditary Cancer Syndrome",
      "Kidney Diseases",
      "Kidney Transplant Rejection",
      "Kidney Transplantation, Acute Rejection of Renal Transplant",
      "Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8",
      "Lung Transplant Rejection",
      "Lung Transplantation",
      "Metastatic Breast Cancer, HER2-positive Breast Cancer",
      "Microdeletion Syndromes, Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Abnormalities",
      "Muscle-Invasive Bladder Carcinoma",
      "Muscle-invasive Bladder Cancer",
      "NSCLC, Stage I, II, III",
      "Pancreas Cancer",
      "Pancreatic Cancer",
      "Pregnancy Following IVF With PGS/PGD",
      "Preimplantation Gentic Screening (PGS), In Vitro Fertilization (IVF), Preimplantation Genetic Diagnosis (PGD)",
      "Rectal Adenocarcinoma",
      "Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8",
      "Single Gene NIPT",
      "Spinal Muscular Atrophy (SMA), Carrier Screening, Genetic Testing",
      "Stage III Colon Cancer",
      "Transplant Rejection, Allograft Rejection, Complications",
      "Trisomy 13, Trisomy 18, Trisomy 21, Aneuploidy",
      "Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities",
      "Trisomy 21, Trisomy 18, Trisomy 13, Monosomy X",
      "Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Abnormalities, Microdeletion Syndromes",
      "Urothelial Carcinoma",
      "Vanishing Twin, Trisomy 21, Trisomy 13, Trisomy 18"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:43:14.969546",
    "search_query": "Natera, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Natera,+Inc."
  }
}